Metraipolis › archive › dc_a537c3aa205a
Circulating tumor DNA and Response Evaluation Criteria In Solid Tumors: ctDNA-RECIST proof-of-concept in HER2-positive metastatic breast cancer — Europe PMC PMID:41559726
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41559726
- DOI
- 10.1186/s13046-[numero omesso]-2
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-06T16:49:45.802Z
- SHA-256 of the archived text
462ddf7af350e3457037e087e0479981c5b2eebabfc339c7b19c4a8b8ea13787- Stable URL of this page
https://metraipolis.com/documento/dc_a537c3aa205a
How to cite
Circulating tumor DNA and Response Evaluation Criteria In Solid Tumors: ctDNA-RECIST proof-of-concept in HER2-positive metastatic breast cancer — Europe PMC PMID:41559726 — Europe PMC (en), https://europepmc.org/article/MED/41559726 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a537c3aa205a (Metraipolis archive dc_a537c3aa205a, sha256 462ddf7af350e3457037e087e0479981c5b2eebabfc339c7b19c4a8b8ea13787)
BibTeX
@misc{dca537c3aa205a,
title = {Circulating tumor DNA and Response Evaluation Criteria In Solid Tumors: ctDNA-RECIST proof-of-concept in HER2-positive metastatic breast cancer — Europe PMC PMID:41559726},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41559726},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a537c3aa205a; sha256 462ddf7af350e3457037e087e0479981c5b2eebabfc339c7b19c4a8b8ea13787},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41559726. Agents can read the archived copy with the MCP tool read_document.